After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Pasithea Therapeutics Corp is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Pasithea Therapeutics Corp is $7.01M. A total of 0.49 million shares were traded on the day, compared to an average of 5.87M shares.
In the most recent transaction, Tiago Reis Marques bought 960 shares of KTTA for 0.83 per share on May 12 ’25. In a previous transaction on May 12 ’25, Marques Tiago sold 960 shares at 0.82 per share. KTTA shares that Chief Executive Officer owns now total 40,001.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, KTTA has a high of $7.50 and a low of $0.80.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. KTTA’s latest balance sheet shows that the firm has $52.97M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $447.28k in liabilities at the time. Its Book Value Per Share was $4.80, while its Total Shareholder’s Equity was $51.42M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
